Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Standard Versus Continuous Capecitabine in Advanced Breast Cancer

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified March 2011 by Hospital San Carlos, Madrid.
Recruitment status was:  Active, not recruiting
Sponsor:
Collaborator:
Hospital Juan Canalejo, La Coruña, Spain
Information provided by:
Hospital San Carlos, Madrid
ClinicalTrials.gov Identifier:
NCT00418028
First received: January 3, 2007
Last updated: August 8, 2011
Last verified: March 2011